Home Tags Pathologic complete response

Tag: pathologic complete response

Trastuzumab Deruxtecan Demonstrates Clinical Activity in Neoadjuvant Setting in Patients with...

Patients diagnosed with hormone receptor-positive (HR+)/HER2-negative breast cancer frequently experience disease response to neoadjuvant therapy. However, following standard chemotherapy or endocrine therapy, even in combination with CDK4/6...

ADAPT Study Shows Promising Results in the Treatment of Patients with...

Results from the German phase II ADAPT study (WSG-ADAPT), showed that neoadjuvant ado-trastuzumab emtansine (T-DM1, Kadcyla®; Genentech/Roche) is effective in the treatment of HER2-positive,...

X